These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 22085498)

  • 1. E-cadherin cell-cell communication in melanogenesis and during development of malignant melanoma.
    Kuphal S; Bosserhoff AK
    Arch Biochem Biophys; 2012 Aug; 524(1):43-7. PubMed ID: 22085498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of E- and P-cadherin in the human skin.
    Furukawa F; Fujii K; Horiguchi Y; Matsuyoshi N; Fujita M; Toda K; Imamura S; Wakita H; Shirahama S; Takigawa M
    Microsc Res Tech; 1997 Aug; 38(4):343-52. PubMed ID: 9297684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subtypes of melanocytes and melanoma cells distinguished by their intercellular contacts: heterotypic adherens junctions, adhesive associations, and dispersed desmoglein 2 glycoproteins.
    Rickelt S; Franke WW; Doerflinger Y; Goerdt S; Brandner JM; Peitsch WK
    Cell Tissue Res; 2008 Dec; 334(3):401-22. PubMed ID: 18975006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of E-cadherin and Desmoglein 1 by autocrine hepatocyte growth factor during melanoma development.
    Li G; Schaider H; Satyamoorthy K; Hanakawa Y; Hashimoto K; Herlyn M
    Oncogene; 2001 Dec; 20(56):8125-35. PubMed ID: 11781826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of cadherin/catenin complex in malignant melanoma.
    Bonitsis N; Batistatou A; Karantima S; Charalabopoulos K
    Exp Oncol; 2006 Sep; 28(3):187-93. PubMed ID: 17080010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells.
    Li G; Satyamoorthy K; Herlyn M
    Cancer Res; 2001 May; 61(9):3819-25. PubMed ID: 11325858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E-cadherin/catenin complex in benign and malignant melanocytic lesions.
    Silye R; Karayiannakis AJ; Syrigos KN; Poole S; van Noorden S; Batchelor W; Regele H; Sega W; Boesmueller H; Krausz T; Pignatelli M
    J Pathol; 1998 Dec; 186(4):350-5. PubMed ID: 10209482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. H-cadherin expression reduces invasion of malignant melanoma.
    Kuphal S; Martyn AC; Pedley J; Crowther LM; Bonazzi VF; Parsons PG; Bosserhoff AK; Hayward NK; Boyle GM
    Pigment Cell Melanoma Res; 2009 Jun; 22(3):296-306. PubMed ID: 19368692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adhesion, migration and communication in melanocytes and melanoma.
    Haass NK; Smalley KS; Li L; Herlyn M
    Pigment Cell Res; 2005 Jun; 18(3):150-9. PubMed ID: 15892711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E-cadherin and beta-catenin expression patterns in malignant melanoma assessed by image analysis.
    Pećina-Slaus N; Zigmund M; Kusec V; Martić TN; Cacić M; Slaus M
    J Cutan Pathol; 2007 Mar; 34(3):239-46. PubMed ID: 17302608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of the cytoplasmic domain of E-cadherin on endogenous N-cadherin expression in malignant melanoma.
    Kuphal S; Bosserhoff AK
    Oncogene; 2006 Jan; 25(2):248-59. PubMed ID: 16132038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of melanocytic malignancy by keratinocytes is an E-cadherin-mediated process overriding beta-catenin signaling.
    Li G; Fukunaga M; Herlyn M
    Exp Cell Res; 2004 Jul; 297(1):142-51. PubMed ID: 15194432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homo- and heterotypic cell contacts in malignant melanoma cells and desmoglein 2 as a novel solitary surface glycoprotein.
    Schmitt CJ; Franke WW; Goerdt S; Falkowska-Hansen B; Rickelt S; Peitsch WK
    J Invest Dermatol; 2007 Sep; 127(9):2191-206. PubMed ID: 17495963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamics of cell interactions and communications during melanoma development.
    Li G; Satyamoorthy K; Herlyn M
    Crit Rev Oral Biol Med; 2002; 13(1):62-70. PubMed ID: 12097238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic significance of dysadherin expression in cutaneous malignant melanoma: immunohistochemical analysis of 115 patients.
    Nishizawa A; Nakanishi Y; Yoshimura K; Sasajima Y; Yamazaki N; Yamamoto A; Hanada K; Kanai Y; Hirohashi S
    Cancer; 2005 Apr; 103(8):1693-700. PubMed ID: 15751018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional implication of truncated P-cadherin expression in malignant melanoma.
    Bauer R; Bosserhoff AK
    Exp Mol Pathol; 2006 Dec; 81(3):224-30. PubMed ID: 16919267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cadherin expression in melanocytic naevi and malignant melanomas.
    Cowley GP; Smith ME
    J Pathol; 1996 Jun; 179(2):183-7. PubMed ID: 8758211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A secreted form of P-cadherin is expressed in malignant melanoma.
    Bauer R; Hein R; Bosserhoff AK
    Exp Cell Res; 2005 May; 305(2):418-26. PubMed ID: 15817166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of P-cadherin distinct from that of E-cadherin in re-epithelialization in neonatal rat skin.
    Koizumi M; Matsuzaki T; Ihara S
    Dev Growth Differ; 2005 Feb; 47(2):75-85. PubMed ID: 15771627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal human melanocyte homeostasis as a paradigm for understanding melanoma.
    Haass NK; Herlyn M
    J Investig Dermatol Symp Proc; 2005 Nov; 10(2):153-63. PubMed ID: 16358819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.